CCI Approves KKR-Linked Maybach Asia Holdings’ Acquisition of Sahrudaya Health Care

The Competition Commission of India (CCI) has approved the acquisition of 100% of the equity share capital of Sahrudaya Health Care Private Limited by Maybach Asia Holdings II Pte. Ltd., according to a press release issued by the Press Information Bureau (PIB) on October 22, 2026. The proposed combination involves the complete acquisition of the target company by the acquiring entity.

Acquirer Linked to KKR & Co. Inc.

Maybach Asia Holdings II Pte. Ltd. is a special purpose vehicle (SPV) incorporated solely for the proposed transaction. It is indirectly owned by investment funds, vehicles and/or accounts advised and managed by various subsidiaries of KKR & Co. Inc.

About Sahrudaya Health Care

Sahrudaya Health Care Private Limited, directly and through its subsidiaries, operates a multi-specialty hospital network across southern and western India. As reflected in the press release, the network comprises:

• 28 hospitals/units
• Approximately 4,800 beds
• More than 80 clinical specialties

Its areas of medical and surgical care include cardiology, neurology, gastroenterology, nephrology, oncology, orthopedics, critical care and women's health, among other specialties.